These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22345678)

  • 1. A comparative analysis of three widely used lipid management guidelines in the EPIC-Norfolk cohort.
    Colkesen EB; Jørstad HT; Peters RJ; Boekholdt SM; Tijssen JG; Ferket BS; Wareham NJ; Khaw KT
    Eur J Prev Cardiol; 2013 Feb; 20(1):98-106. PubMed ID: 22345678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ACC/AHA and ESC Guideline Recommendations Following Trial Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: Results From the Population-Based Rotterdam Study.
    Pavlovic J; Greenland P; Deckers JW; Brugts JJ; Kavousi M; Dhana K; Ikram MA; Hofman A; Stricker BH; Franco OH; Leening MJ
    JAMA Cardiol; 2016 Sep; 1(6):708-13. PubMed ID: 27439175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major Guidelines for Sensitivity, Specificity, and Number Needed to Treat.
    Mortensen MB; Nordestgaard BG
    JAMA Cardiol; 2019 Nov; 4(11):1131-1138. PubMed ID: 31577339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American, British and European recommendations for statins in the primary prevention of cardiovascular disease applied to British men studied prospectively.
    McElduff P; Jaefarnezhad M; Durrington PN
    Heart; 2006 Sep; 92(9):1213-8. PubMed ID: 16717068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of application of the ACC/AHA guidelines, Adult Treatment Panel III guidelines, and European Society of Cardiology guidelines for cardiovascular disease prevention in a European cohort.
    Kavousi M; Leening MJ; Nanchen D; Greenland P; Graham IM; Steyerberg EW; Ikram MA; Stricker BH; Hofman A; Franco OH
    JAMA; 2014 Apr; 311(14):1416-23. PubMed ID: 24681960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time to improve statin prescription guidelines in low-risk patients?
    Balder JW; de Vries JK; Mulder DJ; Kamphuisen PW
    Eur J Prev Cardiol; 2017 Jul; 24(10):1064-1070. PubMed ID: 28429651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CAC Score Improves Coronary and CV Risk Assessment Above Statin Indication by ESC and AHA/ACC Primary Prevention Guidelines.
    Mahabadi AA; Möhlenkamp S; Lehmann N; Kälsch H; Dykun I; Pundt N; Moebus S; Jöckel KH; Erbel R;
    JACC Cardiovasc Imaging; 2017 Feb; 10(2):143-153. PubMed ID: 27665163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins for primary prevention of cardiovascular disease: modelling guidelines and patient preferences based on an Irish cohort.
    Byrne P; Cullinan J; Gillespie P; Perera R; Smith SM
    Br J Gen Pract; 2019 Jun; 69(683):e373-e380. PubMed ID: 31015226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new approach to test validity and clinical usefulness of the 2013 ACC/AHA guideline on statin therapy: A population-based study.
    Khalili D; Asgari S; Hadaegh F; Steyerberg EW; Rahimi K; Fahimfar N; Azizi F
    Int J Cardiol; 2015 Apr; 184():587-594. PubMed ID: 25769004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-life evaluation of European and American high-risk strategies for primary prevention of cardiovascular disease in patients with first myocardial infarction.
    Mortensen MB; Falk E
    BMJ Open; 2014 Oct; 4(10):e005991. PubMed ID: 25326211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of statin guidelines on statin utilization and costs in an employer-based primary care clinic.
    Gurgle HE; Schauerhamer MB; Rodriguez SA; McAdam-Marx C
    Am J Manag Care; 2017 Dec; 23(12):e387-e393. PubMed ID: 29261246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Five Major Guidelines for Statin Use in Primary Prevention in a Contemporary General Population.
    Mortensen MB; Nordestgaard BG
    Ann Intern Med; 2018 Jan; 168(2):85-92. PubMed ID: 29297004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study.
    Pavlović J; Greenland P; Deckers JW; Kavousi M; Hofman A; Ikram MA; Franco OH; Leening MJ
    Eur J Prev Cardiol; 2018 Mar; 25(4):420-431. PubMed ID: 29171772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations and Associated Levels of Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: A Comparison at Population Level of the American Heart Association/American College of Cardiology/Multisociety, US Preventive Services Task Force, Department of Veterans Affairs/Department of Defense, Canadian Cardiovascular Society, and European Society of Cardiology/European Atherosclerosis Society Clinical Practice Guidelines.
    Pavlović J; Greenland P; Franco OH; Kavousi M; Ikram MK; Deckers JW; Ikram MA; Leening MJG
    Circ Cardiovasc Qual Outcomes; 2021 Sep; 14(9):e007183. PubMed ID: 34546786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of the 2014 NICE cholesterol guidelines in the English population: a cross-sectional analysis.
    Ueda P; Lung TW; Clarke P; Danaei G
    Br J Gen Pract; 2017 Sep; 67(662):e598-e608. PubMed ID: 28760741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment gaps and potential cardiovascular risk reduction from expanded statin use in the US and England.
    Ueda P; Lung TW; Lu Y; Salomon JA; Rahimi K; Clarke P; Danaei G
    PLoS One; 2018; 13(3):e0190688. PubMed ID: 29561843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population health impact of statin treatment in Canada.
    Hennessy DA; Tanuseputro P; Tuna M; Bennett C; Perez R; Shields M; Ko DT; Tu J; Manuel DG
    Health Rep; 2016 Jan; 27(1):20-8. PubMed ID: 26788719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2019 vs. 2016 ESC/EAS statin guidelines for primary prevention of atherosclerotic cardiovascular disease.
    Mortensen MB; Nordestgaard BG
    Eur Heart J; 2020 Aug; 41(31):3005-3015. PubMed ID: 32227172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of four international cardiovascular disease prediction models and the prevalence of eligibility for lipid lowering therapy in HIV infected patients on antiretroviral therapy.
    Begovac J; Dragović G; Višković K; Kušić J; Perović Mihanović M; Lukas D; Jevtović Đ
    Croat Med J; 2015 Feb; 56(1):14-23. PubMed ID: 25727038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Guideline-based statin/lipid-lowering therapy eligibility for primary prevention and accuracy of coronary artery calcium and clinical cardiovascular events: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Flueckiger P; Qureshi W; Michos ED; Blaha M; Burke G; Sandfort V; Herrington D; Yeboah J
    Clin Cardiol; 2017 Mar; 40(3):163-169. PubMed ID: 27859433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.